Sublobar Resection Should Be New Standard Care for Certain Patients With NSCLC
Sublobar resection is noninferior to a full lobectomy in patients with carefully staged cT1aN0 non-small cell lung cancer, new research suggests.
IASLC
COVID-19 Should Not Delay Cancer Treatment in Patients With Thoracic Cancer, Data Suggest
Recent exposure to systemic treatment does not increase the risk of 30-day mortality in patients with thoracic cancers and COVID-19.
Long-Term Exposure to Air Pollution and Risk of Lung Cancer
Long-term cumulative exposure to air pollution should be included in assessments of lung cancer risk, according to researchers.
Consent Forms for Clinical Trials Prove Too Long and Complex for Patients
Consent forms could be improved by a patient-centric addendum highlighting key points, a study suggests.
First-Line Pembrolizumab Improves Outcomes in Extensive-Stage Small Cell Lung Cancer
Adding pembrolizumab to chemotherapy can improve survival in extensive-stage small cell lung cancer, a phase 3 study suggests.
Sexual Dysfunction Common but Unique in Women With Lung Cancer
Researchers found that 77% of patients had moderate to severe sexual dysfunction.
Earlier Detection of Non-Small Cell Lung Cancer Needed for Younger Patients
Advanced disease at diagnosis is more likely among younger patients with non-small cell lung cancer, according to a new study.
Vaccination May Prevent Severe COVID-19 in Patients With Lung Cancer
COVID-19 vaccination does not appear to prevent SARS-CoV-2 infection in patients with lung cancer, but it may prevent severe COVID-19.
Sugemalimab Consolidation Could Be New Standard in Stage III NSCLC
Sugemalimab consolidation improved progression-free survival, when compared with placebo, in patients with unresectable, stage III non-small cell lung cancer.
Neoadjuvant Nivolumab Improves PFS, OS in Stage IIIA-B Non-Small Cell Lung Cancer
Adding nivolumab to neoadjuvant platinum-based chemotherapy can improve survival in patients with stage IIIA-B non-small cell lung cancer, new data suggest.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in WCLC 2022
Loading... 
Loading...